The New Delhi Metallo-b-lactamase (NDM-1) gene makes multiple pathogenic microorganisms resistant to all known b-lactam antibiotics. The rapid emergence of NDM-1 has been linked to mobile plasmids that move between different strains resulting in world-wide dissemination. Biochemical studies revealed that NDM-1 is capable of efficiently hydrolyzing a wide range of b-lactams, including many carbapenems considered as ‘‘last resort’ ’ antibiotics. The crystal structures of metal-free apo- and monozinc forms of NDM-1 presented here revealed an enlarged and flexible active site of class B1 metallo-b-lactamase. This site is capable of accommodating many b-lactam substrates by having many of the catalytic residues on flexible loops, which explains ...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The New Delhi Metallo-β-lactamase (NDM-1) gene makes multiple pathogenic microorganisms resistant to...
The New Delhi Metallo-β-lactamase (NDM-1) gene makes multiple pathogenic microorganisms resistant to...
Carbapenems are one of the last lines of defense for Gram-negative pathogens, such as members of the...
The New Delhi Metallo-b-lactamase (NDM-1) was first reported in 2009 in a Swedish patient. A recent ...
Antibiotic resistance in bacterial pathogens poses a serious threat to human health and the metallo-...
Metallo-β-lactamases (MBLs) hydrolyze most β-lactam antibiotics, and bacteria containing this kind o...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
Metallo-beta-lactamases (MBLs) are important enzymatic factors in resistance to beta-lactam antibiot...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The New Delhi Metallo-β-lactamase (NDM-1) gene makes multiple pathogenic microorganisms resistant to...
The New Delhi Metallo-β-lactamase (NDM-1) gene makes multiple pathogenic microorganisms resistant to...
Carbapenems are one of the last lines of defense for Gram-negative pathogens, such as members of the...
The New Delhi Metallo-b-lactamase (NDM-1) was first reported in 2009 in a Swedish patient. A recent ...
Antibiotic resistance in bacterial pathogens poses a serious threat to human health and the metallo-...
Metallo-β-lactamases (MBLs) hydrolyze most β-lactam antibiotics, and bacteria containing this kind o...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
Metallo-beta-lactamases (MBLs) are important enzymatic factors in resistance to beta-lactam antibiot...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease. Recent...